Vuélvete ilimitado con Magzter GOLD
Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo
Intentar ORO - Gratis
Decoding the charm of OpenClaw in China
Financial Express Mumbai
|March 12, 2026
OPENCLAW, AN OPEN-SOURCE AI agent framework, has rapidly attracted attention among developers worldwide.
In China, however, the excitement appears particularly intense. Major tech giants like Alibaba, Tencent, and Baidu are offering services around it. Many of these companies are offering installation services where technicians help users set up OpenClaw on their computers.For the uninitiated, OpenClaw is a type of AI assistant that can run on its own without relying on a human operator to give it instructions. While popular AI tools such as chatbots answer queries and engage in conversations, OpenClaw has been designed to act like a digital assistant that keeps running 24x7, monitoring tasks and taking actions autonomously.
Esta historia es de la edición March 12, 2026 de Financial Express Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Financial Express Mumbai
Financial Express Mumbai
Banks still hold back on NDF contracts for clients
BANKS ARE STILL holding back from offering rupee non-deliverable forwards to clients, despite the Reserve Bank of India (RBI) lifting restrictions imposed three weeks ago when the rupee slid to an all-time low, four sources said.
2 mins
April 22, 2026
Financial Express Mumbai
Tougher disclosure norms for Al content proposed
THE GOVERNMENT ON Tuesday mooted stricter disclosure norms for AI-generated content, proposing tweaks to the IT Rules that would require clear and continuous labels identifying synthetically generated information to be visible throughout the entire duration of the visual display.
1 mins
April 22, 2026
Financial Express Mumbai
OneSource, partner get tentative FDA nod for semaglutide injection
ONESOURCE SPECIALTY PHARMA has announced that its partner, Orbicular Pharmaceutical Technologies, along with its US-based front-end partner, has secured tentative approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application for a generic version of Ozempic semaglutide injection.
1 min
April 22, 2026
Financial Express Mumbai
OVL to invest $1.17 bn in Brazil block
Govt evaluating offshore unit investment plan
1 mins
April 22, 2026
Financial Express Mumbai
Exporters hope for US tariff refund of $12 bn
INDIAN EXPORTERS WHOSE goods were subject to reciprocal and penal tariffs of about $12 billion in the US market can hope to get a portion of it back as the US Customs and Border Protection (CBP) has started accepting applications for refunds.
2 mins
April 22, 2026
Financial Express Mumbai
Trump says ‘ready to bomb’ as clock ticks on ceasefire
THE US IS still in the dark on whether Iran will take part in fresh talks to end the war before a ceasefire expires around Wednesday, with the sides deadlocked on issues including access to the Strait of Hormuz.
2 mins
April 22, 2026
Financial Express Mumbai
The Ternus test
Al DISRUPTION FORCES APPLE TO RETHINK PLAN AS LEADERSHIP BATON PASSES TO A PRODUCT-FOCUSED INSIDER
2 mins
April 22, 2026
Financial Express Mumbai
Recruitment advertising at a crossroads
RECRUITMENT IS NO longer a structured formal introduction.
2 mins
April 22, 2026
Financial Express Mumbai
‘Our strategic focus stays on emerging & affordable housing’
PNB Housing Finance is targetting the ®1 lakh-crore assets under management (AUM) milestone within the next six months, with affordable and emerging housing poised to drive the company’s next phase of expansion, Managing Director and Chief Executive Ajai Shukla tells Kshipra Petkar and Mahesh Nayak in an interview.
2 mins
April 22, 2026
Financial Express Mumbai
Nestle delivers double-digit volume growth
Profit rises 26% in March qtr; sales highest in a decade
2 mins
April 22, 2026
Listen
Translate
Change font size